[Cancer of the pharynx--results of treatment with cobalt-60].
One hundred two patients with pharyngeal cancer had been treated from 1980 to 1984 in Center Oncology--Institute branch Gliwice. Total radiation doses were 60-65 Gy. From the group of 44 patients without metastatic lymph nodes, 5 year survival rate was 36%. In cases with advanced pharyngeal carcinoma and with metastases to the lymph nodes (58 patients), 5 year survival rate was 18%. The results of this study suggest that survival rates depend on the size of the tumor and presence metastases to the local lymph nodes.
Wojcieszek
Z
Z
Zakładu Teleradioterapii Centrum Onkologii, Instytutu Oddział, Gliwicach.
D000328:Adult; D000368:Aged; D003037:Cobalt Radioisotopes / Q000008:administration & dosage*; D006801:Humans; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009367:Neoplasm Staging; D010610:Pharyngeal Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D011379:Prognosis; D011879:Radiotherapy Dosage; D013997:Time Factors
D003037:Cobalt Radioisotopes
Rak gardła--wyniki leczenia kobaltem 60.